A future without genetic diseases is an ambitious goal, but advancements in CRISPR bring us closer. The Danaher-IGI Beacon unites scientific leaders to accelerate CRISPR cures and advance genomic medicine. Greg Milosevich emphasizes that by combining expertise and technology, we can bring life-changing treatments to patients more efficiently. Join us at American Society of Gene & Cell Therapy (ASGCT) for a Breakfast Symposium on CRISPR Cures! Register now: https://bit.ly/41LMBR5 Danaher Corporation Innovative Genomics Institute
Danaher Life Sciences
生物技术研究
Framingham，Massachusetts 29,443 位关注者
Innovation at the speed of life
关于我们
The Life Sciences companies of Danaher integrate the deep scientific expertise of our individual operating companies with the robust engineering know-how of the Danaher Business System to create innovative workflows that significantly bend the drug development time curve. Every day, scientists around the world are working to understand the causes of disease, develop new therapies and vaccines, and test new drugs. These life science companies make this leading-edge scientific research possible. Our capabilities extend beyond research to power the creation of biopharmaceuticals, cell and gene therapies, and other breakthrough treatments to advance patient health and improve treatment outcomes. Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond.
- 网站
-
https://lifesciences.danaher.com/?utm_source=dhrls_linkedin&utm_medium=social
Danaher Life Sciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 超过 10,001 人
- 总部
- Framingham，Massachusetts
- 类型
- 上市公司
动态
-
Why do so many drug candidates fail in late-stage trials? Conventional cell and animal models often miss the mark in predicting human responses. 3D organoids provide a more accurate alternative, replicating tissue microenvironments and biological processes, but scalability is a challenge. Discover how Molecular Devices enhances the reliability and reproducibility of 3D cell culture and cell-based assays: https://bit.ly/43Vl2Y3 #Organoids #3DCellCulture #HumanRelevantModels #DrugDiscovery
-
3.141592653… Happy Pi Day! Just as Pi (π), a fundamental constant driving precision in science, ensures accuracy in physics and engineering, the Life Sciences companies of Danaher equip researchers with advanced tools to transform complex data into actionable insights, accelerating innovation and improving patient health. Enjoy a slice of pie with us while shaping the future of science! #PiDay #DrugDiscovery #Biopharma #GenomicMedicine #PrecisionScience
-
-
Join Leica Microsystems, Genedata, and Abcam at the Spatial Omics & AI symposium to explore how spatial proteomics, advanced imaging, and AI can accelerate your translational research. Connect with industry experts and gain actionable insights to improve efficiency, reproducibility, and impact in your research programs. Register now: https://bit.ly/41FQA1r #SpatialProfiling #AI #DrugDiscovery #TranslationalMedicine
-
-
Danaher Corporation and the Innovative Genomics Institute (IGI) are collaborating to accelerate CRISPR-based gene editing for rare and complex diseases. The Danaher-IGI Beacon for CRISPR Cures seeks to use the power of CRISPR-based gene editing to permanently address hundreds of diseases with a unified scientific and technological approach – one designed to parallel-track and accelerate the development of dozens or even hundreds of therapies for diseases that might otherwise never be treated. Join Sadik Kassim and Fyodor Urnov at American Society of Gene & Cell Therapy (ASGCT) for a Breakfast Symposium on CRISPR Cures! Register now: https://bit.ly/3XyfHSx
-
-
International Women’s Day is a time to reflect, and at Danaher Life Sciences, we are proud to be part of a broader commitment to action. Through mentorship, leadership development, and the Women + Friends Associate Resource Groups, Danaher Corporation empowers women across industries to grow, lead, and drive meaningful impact. We take action every day to foster inclusion, representation, and success. Let’s keep moving forward together! #IWD2025 #AccelerateAction
-
-
Don't miss out on this exciting program from Aldevron ?? The Aldevron Breakthrough Booster Program is here to support your therapeutic development journey. Enjoy six months of cost savings, access to technical experts, and free evaluations. Apply today and let them help you progress smoothly. #BiotechSupport #Therapeutics #danaher #speedoflife https://lnkd.in/gJv5bzJ6
-
Congratulations Genedata on your award for webinar of the year!
Exciting news from #SLAS2025! Martin Jockel and Felix Stemmer from Novartis won the "Drug Discovery & Development Webinar of the Year" award from SelectScience? for their webinar showcasing how Gendata software solutions increased efficiency and reduced analysis time of Mass Spec data. ?? Don't miss the?final opportunity today to visit the Genedata booth #1825 and explore our advanced solutions for screening data management. We are happy to show you how we support your complex and ultra-high throughput experiments. We look forward to seeing you! #DigitalizingBiopharma #Innovation #DataAnalysis #LifeSciences?
-
-
The Life Sciences Companies of Danaher are excited to speak to you at SLAS 2025. Stop by booth #1619 to speak with our subject matter experts. Abcam Beckman Coulter Life Sciences Cytiva Genedata IDBS Leica Microsystems Molecular Devices Phenomenex SCIEX
-
-
What if you could revolutionize drug discovery and improve clinical trial success rates? #Organoid technologies show great promise in better predicting drug responses, but technical challenges hinder their wider adoption. Join us at SLAS (Society for Laboratory Automation and Screening) on January 28th for an in-depth tutorial where we’ll demonstrate how to generate reliable and reproducible results from complex assays using fully automated workflows and machine learning-based decision-making. Is your lab ready to transform drug screening and disease modeling and pave the way to more predictive #drugdiscovery???? https://bit.ly/4fRXHZR ? #SLAS2025 #MolDevAtSLAS2025 #CellCulture #LabAutomation #DrugDevelopment #MachineLearning #TheFutureOfCellCulture #AutomatedWorkflow #CellXpressAI #DeeperInsightsForEveryLab
-